Zhejiang Yongtai Technology Co.,Ltd. (002326.SZ)
Linhai, CN
Zhejiang Yongtai Technology Co., Ltd., which commenced operations in 1999 and is headquartered in Linhai, China, primarily focuses on the innovation, production, and distribution of fluorine-based chemicals throughout the country. The company's offerings include fluorinated compounds essential for pharmaceutical applications, serving a wide array of medicinal fields such as anti-diabetic, antiviral, cardiovascular, quinolone-type antibacterial, and nervous system treatments. Additionally, they provide chemical intermediates utilized in the formulation of insecticides and fungicides. Furthermore, Zhejiang Yongtai Technology diversifies its portfolio with materials for liquid crystal displays, lithium-ion batteries, and various other energy-related products. They also extend custom manufacturing solutions to partners within the pharmaceutical and general chemical sectors.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.91% | -8.81% | -15.82% | -16.06% | -19.42% | -16.93% | +74.24% | +26.07% | +73.08% | +39.24% | +325.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+13.6% ★ Q1'26: +59.7% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+90.4% ★ Q1'26: +900.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-12.0% Q1'26: -3.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+1.8% Q1'26: +13.5% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.1% Q1'26: +9.6% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.4% ★ Q1'26: -3.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×9.88× Q1'26: 3.95× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
Dec 2032 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.54B
est: 1.43B (+7.8%)
|
1.75B
est: 1.80B (-2.7%)
|
2.75B
est: 2.52B (+9.3%)
|
3.30B
est: 3.02B (+9.3%)
|
3.43B
est: 4.14B (-17.2%)
|
3.45B
est: 5.43B (-36.5%)
|
4.90B
est.
|
4.47B
est: 8.56B (-47.8%)
|
6.32B
est: 8.56B (-26.2%)
|
4.13B
est: 11.78B (-65.0%)
|
4.59B
est: 4.59B (+0.0%)
|
2.52B
2.52B – 2.52B
-45.1% YoY
|
3.02B
3.02B – 3.02B
+19.8% YoY
|
4.14B
4.14B – 4.14B
+37.4% YoY
|
5.43B
5.43B – 5.43B
+31.0% YoY
|
4.90B
4.90B – 4.90B
-9.8% YoY
|
8.56B
8.56B – 8.56B
+74.7% YoY
|
11.78B
11.78B – 11.78B
+37.6% YoY
|
| EBITDA |
341.29M
est: 149.27M (+128.6%)
|
526.87M
est: 187.45M (+181.1%)
|
508.04M
est: 262.66M (+93.4%)
|
813.94M
est: 314.61M (+158.7%)
|
702.99M
est: 432.27M (+62.6%)
|
465.44M
est: 566.42M (-17.8%)
|
511.13M
est.
|
862.20M
est: 892.91M (-3.4%)
|
1.32B
est: 892.91M (+47.5%)
|
-249.86M
est: 1.23B (-120.3%)
|
106.23M
est: 457.91M (-76.8%)
|
242.58M
242.58M – 242.58M
-47.0% YoY
|
290.55M
290.55M – 290.55M
+19.8% YoY
|
399.22M
399.22M – 399.22M
+37.4% YoY
|
523.11M
523.11M – 523.11M
+31.0% YoY
|
472.05M
472.05M – 472.05M
-9.8% YoY
|
824.65M
824.65M – 824.65M
+74.7% YoY
|
1.13B
1.13B – 1.13B
+37.6% YoY
|
| EBIT |
221.14M
est: 33.98M (+550.8%)
|
388.47M
est: 42.67M (+810.4%)
|
316.76M
est: 59.79M (+429.8%)
|
621.48M
est: 71.61M (+767.8%)
|
477.03M
est: 98.40M (+384.8%)
|
206.83M
est: 128.93M (+60.4%)
|
116.35M
est.
|
575.03M
est: 203.25M (+182.9%)
|
957.87M
est: 203.25M (+371.3%)
|
-653.65M
est: 279.71M (-333.7%)
|
-393.64M
est: 88.16M (-546.5%)
|
27.00M
27.00M – 27.00M
-69.4% YoY
|
32.34M
32.34M – 32.34M
+19.8% YoY
|
44.44M
44.44M – 44.44M
+37.4% YoY
|
58.22M
58.22M – 58.22M
+31.0% YoY
|
52.54M
52.54M – 52.54M
-9.8% YoY
|
91.79M
91.79M – 91.79M
+74.7% YoY
|
126.31M
126.31M – 126.31M
+37.6% YoY
|
| Net Income |
144.27M
est: 205.22M (-29.7%)
|
277.02M
est: 188.80M (+46.7%)
|
182.24M
est: 402.24M (-54.7%)
|
441.66M
est: 418.66M (+5.5%)
|
271.70M
est: 432.36M (-37.2%)
|
120.00M
est: 496.75M (-75.8%)
|
377.16M
est.
|
280.29M
est: 1.14B (-75.4%)
|
554.11M
est: 1.14B (-51.4%)
|
-619.76M
est: 1.31B (-147.4%)
|
-478.35M
|
403.16M
403.16M – 403.16M
|
419.62M
419.62M – 419.62M
+4.1% YoY
|
433.35M
433.35M – 433.35M
+3.3% YoY
|
497.89M
497.89M – 497.89M
+14.9% YoY
|
378.03M
378.03M – 378.03M
-24.1% YoY
|
1.14B
1.14B – 1.14B
+202.4% YoY
|
1.31B
1.31B – 1.31B
+14.5% YoY
|
| SGA |
178.89M
est: 210.83M (-15.1%)
|
262.67M
est: 264.75M (-0.8%)
|
373.46M
est: 370.98M (+0.7%)
|
473.53M
est: 444.35M (+6.6%)
|
485.79M
est: 610.53M (-20.4%)
|
530.54M
est: 800.00M (-33.7%)
|
721.91M
est.
|
624.00M
est: 1.26B (-50.5%)
|
733.91M
est: 1.26B (-41.8%)
|
748.70M
est: 1.74B (-56.9%)
|
669.01M
est: 676.15M (-1.1%)
|
358.68M
358.68M – 358.68M
-47.0% YoY
|
429.62M
429.62M – 429.62M
+19.8% YoY
|
590.30M
590.30M – 590.30M
+37.4% YoY
|
773.49M
773.49M – 773.49M
+31.0% YoY
|
697.99M
697.99M – 697.99M
-9.8% YoY
|
1.22B
1.22B – 1.22B
+74.7% YoY
|
1.68B
1.68B – 1.68B
+37.6% YoY
|
| EPS |
0.16
est: 0.22 (-28.3%)
|
0.31
est: 0.21 (+51.0%)
|
0.20
est: 0.44 (-54.3%)
|
0.50
est: 0.46 (+9.9%)
|
0.31
est: 0.47 (-34.0%)
|
0.14
est: 0.54 (-74.1%)
|
0.41
est.
|
0.32
est: 1.24 (-74.2%)
|
0.67
est: 1.24 (-46.0%)
|
-0.69
est: 1.42 (-148.6%)
|
-0.52
|
0.44
0.44 – 0.44
|
0.46
0.46 – 0.46
+4.1% YoY
|
0.47
0.47 – 0.47
+3.3% YoY
|
0.54
0.54 – 0.54
+14.9% YoY
|
0.41
0.41 – 0.41
-24.1% YoY
|
1.24
1.24 – 1.24
+202.4% YoY
|
1.42
1.42 – 1.42
+14.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 208.7K | 0.65% |
| 2 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.02% | 80.6K | 0.49% |
| 3 | State Street SPDR S&P China ETF GXC | 0.01% | 48.6K | 0.59% |
| 4 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 170.2K | 0.19% |
| 5 | Franklin FTSE China ETF FLCH | 0.01% | 19.5K | 0.19% |
| 6 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.01% | 998.5K | 0.07% |
| 7 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 282.0K | 0.06% |
| 8 | Invesco FTSE All-World UCITS ETF FWRA.SW | 0.00% | 91.7K | 0.15% |
| 9 | Invesco FTSE All-World UCITS ETF FTWG.L | 0.00% | 91.5K | 0.15% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 178.9K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chun Hua Wang | Deputy General Manager | — | male |
| Hegeng Wei | Deputy General Manager | — | male |
| Jiangshan Zhang | Deputy GM, Board Secretary & Director | — | male |
| Jianwen Li | Deputy General Manager | — | male |
| Jingfeng Huang | Deputy General Manager | — | male |
| Kuang He | GM, MD & Non Independent Director | — | male |
| Li Jie Chen | Deputy GM, Chief Financial Officer & Non Independent Director | — | female |
| Xiao Hua Zhang | Director of Linhai Production Base Plant | — | male |
| Yang feng Ying | Chief Financial Officer | — | male |
| Yi Zhong Jin | Deputy GM & Non Independent Director | — | male |
| Ying Mei Wang | Co-Founder, GM & Chairman | — | female |
| Zichen Wang | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002326.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
